Skip to main navigation Skip to search Skip to main content

Present and future treatments of dryness in primary Sjögren's syndrome

Research output: Contribution to journalShort surveypeer-review

Abstract

Primary Sjögren's syndrome (pSS) is characterized by the association of a symptomatic triad (dryness, pain and fatigue) with various systemic manifestations. While systemic involvement affects about 30 % of patients, sicca, mainly ocular and oral, is present in almost all patients. This symptom causes high burden of the disease and a marked deterioration in quality of life. It should not be neglected in the management of pSS patients. The purpose of this update is to provide a review of the mechanisms that cause dry syndrome in pSS, to outline the potential consequences of this symptom, and to give practical tools to guide the management of our pSS patients. Finally, this article reviews the impact of targeted therapies in development in pSS on dryness.

Translated title of the contributionTraitements présents et futurs du syndrome sec au cours du syndrome de Gougerot-Sjögren primitif
Original languageEnglish
Pages (from-to)279-286
Number of pages8
JournalRevue du Rhumatisme Monographies
Volume88
Issue number4
DOIs
Publication statusPublished - 1 Sept 2021
Externally publishedYes

Keywords

  • Biologics
  • Sicca
  • Sjögren's syndrome
  • Symptomatic treatment

Fingerprint

Dive into the research topics of 'Present and future treatments of dryness in primary Sjögren's syndrome'. Together they form a unique fingerprint.

Cite this